ACHILLION PHARMACEUTICALS, INC...

Achillion to Present at Three Upcoming Investor Conferences

Achillion to Present at Three Upcoming Investor Conferences

Achillion falls 5.3%

BofA/Merrill Lynch Downgrades Achillion Pharmaceuticals (ACHN) Two-Notches to Underperform

Emerald Holds Annual Groundhog Day Investment Forum

Achillion Announces Executive Promotion

Achillion calls active in renewed takeover chatter

Rumor: Achillion moves up on renewed takeover chatter

Biotech Stock Mailbag: Vival, Hep C Drugs

Top Stock Alerts for Day Traders: Atmel, R.R. Donnelley & Sons, BioLineRx, Achillion Pharmaceuticals, Windstream and Rare Element Resources

24/7 Wall St. Closing Bell (NFLX, PAAS, HAL, HD, KORS, APD, BHI, CLWR, APD, BHI, CLWR, EMC, WDC, CSX, ZION, AAPL, BLRX, LEE, BONT, IDCC, ACHN)

BioLineRx: Tuesday's Hot Hep C Drug Stock

Achillion calls active in renewed takeover chatter

Achillion recent pullback a buying opportunity, says Piper Jaffray

Achillion Shares Have Lost Nearly One Third of their Value Since Rocketing to 52-Wk Highs (NAS,NAS:ACHN,IDIX)

Biotech Buyouts & Deal Flows

Idenix Pharma Buyout Likely: Survey

Biotech Stock Mailbag: Celldex, Hep C Bubble, Al Mann Anger

Achillion moves lower on a Seeking Alpha blog story

Achillion to Present at the Noble Financial Capital Markets' Eighth Annual Equity Conference

A Forward Look, the Year Ahead -- Featured Research on Achillion Pharmaceuticals, Inc. and Nektar Therapeutics

4 Companies That Are Bleeding Cash

More Biotech Lessons Learned From JPM 2012

Merck Is Shopping for Smarts In Hep C

Achillion volatility elevated on wide share price movement

Brean Murray Carret Raises Price Target on Achillion Pharmaceuticals (ACHN) Due to ACH-1625 Clinical Profile

Achillion price target raised to $20 from $9 at Brean Murray

Idenix and Achillion Jump on Takeover Talk

Research Reports on Top Traded Stocks: Zynga, JetBlue Airways, Flextronics, Achillion Pharmaceuticals, Hercules Offshore and Minefinders

J.P. Morgan Biotech Confab Live Chat

Dance Ballmer, dance! Microsoft is back

Achillion Reports Clinical Data on Portfolio of Protease Inhibitors

ACH-1625 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C

Zacks.com featured expert Kevin Matras highlights: Ulta Salon, Cosmetics & Fragrance, Inc., Hexcel Corp., On Assignment, Inc., Advance America, Cash Advance Centers, Inc. and Achillion Pharmaceuticals, Inc.

Achillion Announces Preliminary Phase 1b Proof-of-Concept Data With ACH-2928 NS5A Inhibitor for the Treatment of Hepatitis C

Shares of Achillion Pharmaceuticals (ACHN) Continue Higher Into The Close

Wells Fargo Starts Achillion Pharmaceuticals (ACHN) at Outperform; PI '1625, Though Early, has Best-in-Class Potential

Achillion to Present at the 23rd Annual Piper Jaffray Health Care Conference

Achillion Reports Third Quarter and Nine Month 2011 Financial Results

Achillion Reports Third Quarter and Nine Month 2011 Financial Results